| Medications |
Manufacturer |
Main use |
| Atovaquone |
GlaxoWellcome |
Pneumocystis carinii pneumonia (PCP) |
| Doxycycline |
Non-proprietary |
Infections |
| Doxylar |
Lagap |
Infections |
| Fansidar |
Roche |
Treatment of malaria |
| Fasigyn |
Pfizer |
Anaerobic bacteria |
| Flagyl |
Hawgreen |
Anaerobic bacteria |
| Flagyl S |
Hawgreen |
Anaerobic bacteria |
| Halfan (discontinued in the UK) |
SK & F |
Treatment of chloroquine resistant falciparum malaria |
| Lariam |
Roche |
Prevention of malaria
Treatment of malaria |
| Malarone |
GlaxoWellcome |
Treatment and prevention of malaria |
| Mefloquine |
Roche |
Prevention of malaria
Treatment of malaria |
| Metronidazole Suspension |
|
Anaerobic bacteria |
| Metronidazole Tablets |
Non-proprietary |
Anaerobic bacteria |
| Nivaquine |
Rhone-Poulenc Rorer |
Malaria
Rheumatoid arthritis |
| Paludrine/Avloclor |
AstraZeneca |
Treatment of chloroquine resistant falciparum malaria |
| Primaquine |
Non-proprietary |
Treatment of malaria |
| Quinine Dihydrochloride |
Non-proprietary |
Treatment of malaria |
| Quinine Sulphate |
Non-proprietary |
Treatment of malaria |
| Vibramycin |
Pfizer |
Infections |
| Vibramycin-D |
Pfizer |
Infections |